Verrica Pharmaceuticals Inc. Operating Lease, Payments
Verrica Pharmaceuticals Inc. (VRCA) reported Operating Lease, Payments of $68.00 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-07.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2019-08-07
- Verrica Pharmaceuticals Inc. operating lease, payments for the quarter ending 2019-06-30 was $35.00K.
- Verrica Pharmaceuticals Inc. operating lease, payments for the quarter ending 2019-03-31 was $33.00K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month |
|---|---|---|
| 2019-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $68.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $33.00K 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |